• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Bicalutamide Inovamed 50 mg
    / Inovamed


    Active Ingredient
    Bicalutamide 50 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    28 X 50 mg

    not in the basket chart 39081 2543

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    Treatment of advanced prostate cancer in combination with luteinizing hormone-releasing hormone (LHRH) analog therapy or surgical castration.


    Contra-Indications

    Women and children. Hypersensitivity to the active substance or to any of the excipients. Co-administration with terfenadine, astemizole or cisapride.
    See prescribing information for full details.


    Special Precautions

    See literature and prescribing information for full details.


    Side Effects

    Very common: Dizziness, hot flash,abdominal pain, constipation, nausea, hematuria, gynecomastia, breast tenderness, asthenia, chest pain, edema.
    See literature and prescribing information for full details.


    Drug interactions

    Bicalutamide is an inhibitor of CYP 3A4, with lesser inhibitor effects on CYP 2C9, 2C19 and 2D6 activity. Co-administration with cimetidine and ketoconazole.
    See literature and prescribing information for full details.


    Manufacturer
    Synthon BV
    Licence holder
    CLOSE